GYL Financial Synergies’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $10.2M | Buy |
70,379
+485
| +0.7% | +$70.6K | 0.77% | 30 |
|
|
2024
Q2 | $9.59M | Buy |
69,894
+825
| +1% | +$113K | 0.74% | 30 |
|
|
2024
Q1 | $9.48M | Sell |
69,069
-380
| -0.5% | -$52.1K | 0.74% | 34 |
|
|
2023
Q4 | $9.43M | Sell |
69,449
-1,403
| -2% | -$191K | 0.78% | 31 |
|
|
2023
Q3 | $8.66M | Sell |
70,852
-873
| -1% | -$107K | 0.84% | 29 |
|
|
2023
Q2 | $9.11M | Sell |
71,725
-1,015
| -1% | -$129K | 0.83% | 30 |
|
|
2023
Q1 | $9.4M | Buy |
+72,740
| New | +$9.4M | 1.13% | 26 |
|
|
2022
Q1 | – | Sell |
-1,328
| Closed | -$203K | – | 214 |
|
|
2021
Q4 | $203K | Hold |
1,328
| – | – | 0.05% | 206 |
|
|
2021
Q3 | $215K | Hold |
1,328
| – | – | 0.11% | 179 |
|
|
2021
Q2 | $217K | Sell |
1,328
-129
| -9% | -$21.1K | 0.11% | 172 |
|
|
2021
Q1 | $219K | Hold |
1,457
| – | – | 0.12% | 165 |
|
|
2020
Q4 | $221K | Buy |
+1,457
| New | +$221K | 0.13% | 159 |
|